ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,829Medicare Part D Prescriptions Filled, Including Refills

Rank: 40 out of 1111

$812K Total Retail Price of All Prescriptions

Rank: 73 out of 1111

466 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
67% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 466 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

27% of this provider’s 466 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Risky Drugs to Seniors

3% of this provider’s 15,218 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

38 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
SIMVASTATIN 883 753 1 5
HYDROCODONE-ACETAMINOPHEN 752 552 S3 2 1
FUROSEMIDE 616 553 3 6
POTASSIUM CHLORIDE 555 511 4 9
LISINOPRIL 494 453 5 2
OMEPRAZOLE 456 403 6 4
METOPROLOL TARTRATE 443 413 7 12
LEVOTHYROXINE SODIUM 425 384 8 3
AMLODIPINE BESYLATE 334 301 9 7
WARFARIN SODIUM 321 299 10 19
GABAPENTIN 305 274 11 10
METFORMIN HCL 294 229 12 8
SERTRALINE HCL 269 243 13 24
CITALOPRAM HBR 258 190 14 14
TAMSULOSIN HCL 240 234 15 28
LISINOPRIL-HYDROCHLOROTHIAZIDE 236 199 16 23
POLYETHYLENE GLYCOL 3350 210 182 17 45
TRAMADOL HCL 194 144 18 13
CLONIDINE HCL 192 174 19 42
DONEPEZIL HCL 173 154 20 25
FAMOTIDINE 171 170 21 77
RISPERIDONE 170 134 22 60
ZOLPIDEM TARTRATE 166 142 23 16
CARVEDILOL 157 135 24 21
ATENOLOL 155 126 25 22
ATORVASTATIN CALCIUM 153 106 26 15
HYDROCHLOROTHIAZIDE 148 146 27 11
MELOXICAM 143 126 28 18
PRAVASTATIN SODIUM 142 130 29 17
NAMENDA 134 121 30 31
FENTANYL 129 102 S2 31 65
KLOR-CON M20 129 103 31 79
CLOPIDOGREL 127 122 33 30
GLYBURIDE 127 112 R 33 59
ALLOPURINOL 123 102 35 36
OXYBUTYNIN CHLORIDE ER 123 90 35 114
MIRTAZAPINE 122 112 37 52
NOVOLOG 121 108 38 104
NAPROXEN 118 88 39 85
ISOSORBIDE MONONITRATE ER 117 117 40 73
LEVEMIR 109 93 41 132
GLIPIZIDE 108 96 42 57
TRAZODONE HCL 105 58 43 32
CIPROFLOXACIN HCL 101 91 44 58
ADVAIR DISKUS 94 64 45 43
JANTOVEN 93 93 46 156
ACETAMINOPHEN-CODEINE 92 26 S3 47 140
PREDNISONE 90 69 48 48
PANTOPRAZOLE SODIUM 89 74 49 50
ROPINIROLE HCL 88 78 50 68
SULFAMETHOXAZOLE-TRIMETHOPRIM 87 66 51 71
CYCLOBENZAPRINE HCL 84 44 R 52 37
QUETIAPINE FUMARATE 83 83 53 76
RANITIDINE HCL 83 73 53 29
MEGESTROL ACETATE 83 74 R 53 103
PLAVIX 83 78 53 49
TRIAMTERENE-HCTZ 80 77 57 80
ENALAPRIL MALEATE 78 77 58 56
METOPROLOL SUCCINATE 77 66 59 20
PROAIR HFA 77 60 59 38
DIGOXIN 76 76 61 47
NEXIUM 75 54 62 26
CEPHALEXIN 73 63 63 89
LEVOFLOXACIN 72 68 64 88
PROMETHAZINE HCL 71 56 R 65 69
FLUTICASONE PROPIONATE 69 65 66 27
DIVALPROEX SODIUM 68 43 67 82
CYMBALTA 65 49 68 40
OLANZAPINE 64 48 69 117
LATANOPROST 63 63 70 238
OXYCODONE HCL-ACETAMINOPHEN 63 33 S2 70 86
LOSARTAN POTASSIUM 62 62 72 34
OXYBUTYNIN CHLORIDE 61 59 73 110
LANTUS 58 42 74 46
LYRICA 57 40 75 62
AMOX TR-POTASSIUM CLAVULANATE 56 47 76 141
TRAVATAN Z 56 55 76 183
ALENDRONATE SODIUM 55 55 78 35
CARBIDOPA-LEVODOPA 54 54 79 101
FLUOXETINE HCL 54 50 79 44
AZITHROMYCIN 53 48 81 39
AMLODIPINE BESYLATE-BENAZEPRIL 51 51 82 67
NYSTATIN 50 38 83 151
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 14, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.